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AbstrAct
Objective Previous studies, although inconclusive, have 
suggested possible associations of environmental risk 
factors with the development of giant cell arteritis (gca). 
We aim to investigate seasonal influence on the incidence 
of gca across australia and new Zealand.
Methods in establishing an international study to 
investigate the molecular aetiology of gca, archived 
temporal artery biopsy (taB) specimens primarily from 
australia and new Zealand were obtained. Demographic 
details including age, sex and date of taB were collected 
from collaborating pathology departments. the season in 
which gca was diagnosed was determined and compared 
with previous reports investigating the association 
between environmental risk factors and gca.
Results Our study comprises data from 2224 taB-positive 
patients with gca; 2099 of which were from patients 
in australia and new Zealand. the mean age at time of 
diagnosis was 76.4 years of age. the female-to-male ratio 
was 2.2:1. We noted equal distribution of the incidence 
rate across all four seasons (530–580 cases diagnosed 
every quarter). Statistical analysis of seasonal variation 
by Poisson regression and cosinor methods showed no 
incidence preponderance across seasons. Our results 
do not support a seasonal component contributing to 
the onset of disease. Our literature search identifies no 
consistent environmental risk factor in association with 
gca.
Conclusion this is the largest gca data set reported 
outside of europe. Our results demonstrate equal 
distribution of the incidence rate across all four seasons. 
in contrast to some earlier reports, we did not identify 
evidence of a seasonal component contributing to the 
onset of disease.
InTROduCTIOn
Giant cell arteritis (GCA) is the most common 
chronic systemic inflammatory vasculitis 
affecting people aged over 50 years.1 This 
granulomatous vasculitis primarily targets the 
vessels in the head and neck. The ophthalmic 
artery is commonly affected leading to visual 
loss and as such it is one of the few true 
ophthalmic emergencies. The gold standard 
method to diagnose GCA is through temporal 
artery biopsy (TAB).2
The incidence of GCA rises markedly with 
increasing age, peaking in the seventh decade 
of life.3 4 GCA is most prevalent in populations 
of Scandinavian ancestry. However, GCA has 
been reported in people of African, Asian, 
Hispanic and Arab descents, although inci-
dence among these populations has not been 
clearly studied.2 Given that GCA primarily 
Key messages
What is already known about this subject?
 ► environmental factors have been implicated in the 
development of giant cell arteritis (gca). Yet previous 
study findings have been inconsistent and results 
inconclusive.
What does this study add?
 ► With this geoepidemiological study, we sought to 
identify whether there was indeed a seasonal trend 
in the onset of gca.
 ► We reviewed the demographic data of 2224 obtained 
temporal artery biopsy samples, the largest data set 
in australasia. We found no statistically significant 
difference between seasons with regard to the onset 
of disease.
 ► the results of our systematic literature review 
searching for published associations between 
environmental risk factors and gca highlight that 
there is no convincing and certainly no consistent 
evidence for the role of direct environmental factors 
on the risk of developing gca.
How might this impact on clinical practice?
 ► Our data suggest that seasonality should not be 
viewed as a risk factor for gca in clinical practice. as 
such the month in which a patient presents should 
not influence a clinician’s decision as to whether the 
patient is likely to have gca.
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affects people of Northern European ancestry, there is 
clear evidence for a role of genetic factors in GCA.5–7
Geographical variation, seasonal fluctuations and cyclic 
patterns have been observed in the incidence of GCA.1 
As a result, theories have emerged suggesting an envi-
ronmental, including possibly an infectious aetiology.8–13 
The relative contribution of genetic and environmental 
factors as an explanation for geographical differences in 
GCA incidence remains disputed.14 15
In establishing an international study to investigate the 
molecular aetiology of GCA, archived TAB specimens 
were obtained. Data were collated and analysed from 
pathology centres primarily around Australia and New 
Zealand. Herein we sought to investigate the potential 
pathogenic influence of seasonality on GCA. In addition, 
we report a systematic review of the literature exploring 
the potential non-infectious environmental risk factors 
associated with GCA.
MeTHOds
A total of 28 pathology centres from across Australia 
and New Zealand were approached to participate in this 
study.16 In addition, two sites in Europe collaborated on 
this project. Ethics approval was obtained for all partici-
pating sites (online supplementary appendix A).16 Each 
centre facilitated the collation of details regarding their 
archived TAB formalin-fixed paraffin-embedded (FFPE) 
specimens.
Only TAB samples demonstrating histological evidence 
of GCA as defined by ‘inflammation (granulomatous 
or mixed inflammatory cell infiltrate) of the arterial 
wall with fragmentation and disruption of the internal 
elastic lamina’ were included. Inflammation could also 
involve the media, adventitia and perivascular space (vasa 
vasorum). Multinucleated giant cells may or may not be 
present. Histology reports were obtained and reviewed 
for inclusion criteria. As such we could also ensure that 
the histology recruitment criteria conducted at each 
centre were uniform. Demographic data as well as spec-
imen details were collected on all cases.
Pathologists were each sent a study sample collection 
proforma to complete. Data collected on these forms 
included all relevant details per specimen retrieved: the 
patient’s gender, their date of birth (DOB), the date of 
TAB (DOT) procedure and the hospital location at which 
this procedure was conducted. Pathologists screened 
their local databases to select appropriate cases and 
provided us with the basic data. Given the large volume 
of cases, the patients’ medical records were not requested 
or assessed for detailed clinical information.
The age of patient at time of diagnosis was calculated 
based on the difference between DOB and DOT. Using 
DOT available, we categorised patients by the represen-
tative season in which they were diagnosed. For all states 
within Australia as well as for all participating sites in 
New Zealand, ‘spring’ meant that a patient had under-
gone a TAB procedure during September–November, 
‘summer’ during December–February, ‘autumn’ during 
March–May and ‘winter’ during June–August. As we had 
insufficient data from the Northern Territory, Northern 
Queensland or northern parts of Western Australia, we 
did not use wet or dry season classifications. For Euro-
pean countries, the reverse months and seasons were 
used.
We investigated the relationship between GCA rate 
and seasonal variation by fitting two types of generalised 
linear model. In the first instance, we modelled the 
number of GCA events as a Poisson response with a log 
link function. Season was included as the main effect 
with age and gender as categorical covariates. Seasonal 
trends in GCA rate were also evaluated by performing 
cosinor analysis using the ‘R’ software plug-in ‘season.’ 
The cosinor model assumes a sinusoidal pattern with 
the amplitude describing the size of the seasonal change 
and the phase, its peak. The sinusoid assumes a smooth 
seasonal pattern that is symmetric about its peak (so the 
rate of the seasonal increase in disease is equal to the 
decrease). Age and sex were included as covariates. In 
both types of analyses, models were evaluated for good-
ness of fit.
In addition to our study results, a systematic review of 
publications up to February 2017 was performed using 
the PubMed and ISI Web of Science databases. The search 
criteria included: ‘Giant Cell Arteritis OR temporal arte-
ritis’ AND ‘Country OR geoepidemiology OR seasons OR 
socioeconomic OR environment OR climate OR weather 
OR cyclic OR sunlight OR latitude OR altitude’. Arti-
cles written in English, French or Dutch were reviewed 
for relevance. PRISMA (Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses) guidelines were 
followed.17
Selected studies fulfilled the following criteria: a diag-
nosis of GCA was defined as either having positive TAB, 
a clearly established clinical definition, or meeting the 
American College of Rheumatology classification clinical 
criteria for GCA, and that the study of interest explored 
the association of a specific environmental trigger in the 
context of GCA disease. Articles were excluded if they 
did not distinguish between GCA and polymyalgia rheu-
matic, if they were reviews or if they employed data from 
other studies to explore a larger cohort. When studies 
were updates of previous cohorts, the most recent study 
was used and the most current data were reviewed.
ResulTs
study results
Data from 2224 patients with histologically confirmed 
GCA were included; 1881 samples belonged to patients 
from Australia, 218 from New Zealand and 125 from 
Germany and the Netherlands. The breakdown of the 
sample sizes by states and territories within Australia and 
New Zealand is displayed in table 1. The majority of the 
pathology centres participating in this study were based 
in the Southern States in Australia and as such more 
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cases were recruited from Victoria, South Australia and 
New South Wales.
The TAB FFPE specimens recruited for our GCA 
Genome Wide Association Study (GWAS) dated between 
1987 and 2015 with over 80% of samples belonging to 
patients having undergone their biopsy procedure 
between 2000 and 2015 (online supplementary figure 
1). This is likely to represent an artefact reflecting the 
searchability of hospital databases rather than any true 
increase in incidence in the last 10–15 years.
Participants included 1538 female and 686 male patients 
giving a female:male ratio of 2.2:1. The mean age at DOT 
was 76.4 (SD=7.8) years of age (range 44–97 and median 
76 years of age). The vast majority of patients (46.5%) 
were diagnosed in the seventh decade of life, with the 
eighth decade being the next most common age category 
in which patients present (30.6%) (online supplemen-
tary table 1 and supplementary figure 2). There was no 
statistical difference in the age at diagnosis between men 
and women (76.1 and 76.6 years of age, respectively).
In the Poisson regression, we modelled the number 
of GCA cases as a function of age, gender and season 
(table 2). Age and gender were both noted to influence 
GCA rate, with the number of events being more common 
in women and the elderly. Compared with women (refer-
ence category), men were found to have a 55% reduction 
(1–0.45) in the rate of GCA events (p<0.001). For age, 
compared with the youngest group of participants (40–59 
years—reference category), there was a general trend 
towards increasing rates of GCA in older age groups. 
For example, those aged between 70 and 79 years were 
observed to have an 18-fold increase in the rate of GCA 
events compared with the reference category. There was 
no age–gender interaction on the rate of GCA events.
The distribution of TAB-positive cases across the four 
seasons was equal with approximately 530–580 cases 
being diagnosed each quarter (online supplemen-
tary file 5). Our data revealed no over-riding season in 
which the incidence of GCA predominated in Australia 
or New Zealand, and although our sample cohort from 
Northern Europe was small, there was no season in which 
TAB procedures prevailed more. Poisson regression 
analysis confirmed that there was no statistically signifi-
cant evidence for an association between GCA rate and 
seasonal variation, after adjusting for age and gender. 
With summer as the reference category, the rate ratio 
of GCA approximated the null value (one) for each of 
autumn, spring and winter (table 2). Grouping the colder 
months (autumn and winter) versus the warmer months 
(summer and spring) in the Poison regression analysis 
did not significantly affect the rate ratio (0.94, p=0.17 
with summer/spring as the reference category). Simi-
larly, the results of the cosinor analysis reflected that of 
the Poisson regression (figure 1). While the amplitude of 
the cosine curve was noted to peak in the warmer months 
and trough over winter, this seasonal difference in GCA 
rate was marginal and not statistically significant. As such, 
both types of statistical models support the conclusion 
that we find no evidence for seasonal variation in the rate 
of GCA, after adjusting for age and sex.
systematic review
The results of our systematic review are summarised 
in table 3. Our search determined 104 publications. 






  Victoria (Melbourne) −37.813628 731
  New South Wales (Sydney) −33.868820 467
  Queensland (Brisbane) −27.469771 79
  Tasmania (Hobart) −42.882138 83
  South Australia (Adelaide) −34.928499 290
  Western Australia (Perth) −31.950527 199




  Wellington (Wellington) −41.286460 57
  Canterbury (Christchurch) −43.532054 92
  Otago (Dunedin) −45.878760 69
Europe 125
  The Netherlands (Rotterdam) 51.924420 98
  Germany (Heidelberg) 49.398752 27
Total 2224
Latitude coordinates from http://www.latlong.net.







(Intercept) 10.17 7.66 13.22 <0.001
Season 
(ref=summer)
  Autumn 0.92 0.82 1.04 0.179
  Spring 0.96 0.85 1.08 0.478
  Winter 0.93 0.82 1.04 0.200
Gender 
(ref=female)
  Male 0.45 0.41 0.49 <0.001
Age (ref=40–
59)
  60–69 6.93 5.28 9.26 <0.001
  70–79 18.45 14.24 24.41 <0.001
  80+ 13.34 10.27 17.70 <0.001
The number of giant cell arteritis cases is modelled as a function 
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Following application of the inclusion criteria, we 
included 26 relevant articles investigating a wide range of 
environmental risk factors and their link with the devel-
opment of GCA. Fifteen studies investigated the impact 
of seasons and/or annual cyclic trends and their influ-
ence on the onset of GCA, the results of which seem to be 
inconsistent. Other studies investigated latitude, altitude, 
solar exposure, socioeconomic status (SES) and urban 
versus rural living again with little conclusion.
Seasons and annual cycles
Most of the non-infectious environmental studies in GCA 
cohorts have investigated the aspects of seasonality and/
or cyclic fluctuations of GCA incidence. As demonstrated 
by our literature search findings (table 3), this has been 
a controversial theory; just one third (5 out of 15 studies 
have found a significant association between the onset 
of GCA to occur either within a specific season or that 
certain annual fluctuations are seen. The other studies 
demonstrated no significant seasonal pattern or cyclic 
trend to explain GCA incidence. For those studies that did 
find a peak within certain seasons or months, the trend 
was not consistent; some found more cases in summer 
while others in winter. A Swedish study described a peak 
in GCA incidence rate in autumn and winter,18 while 
studies in the UK and Israel describe a peak in spring and 
summer.9 19 20 There seems to be no overall consensus on 
seasonality and incidence rate of this disease.
latitude and altitude
The increased risk to develop GCA in the Caucasian 
population was previously attributed to a possible theory 
on latitude, where moving away from the equator to 
more northerly latitudes might increase disease risk. A 
Norwegian study did not support this notion; regional 
differences could not be accounted for by a North-South 
gradient.21 In a Swedish study, a lower risk of GCA was 
found in Northern Sweden, suggesting that the high risk 
in Sweden is not caused by a colder climate alone.22 The 
potential role of altitude as a geographical factor has also 
been implicated in the incidence of GCA. Nevertheless, 
a Spanish study assessing altitude at the site of residence 
of 210 patients with GCA within the Lugo region revealed 
no difference in disease incidence related to this variable, 
nor did it account for relapse rates.23
Solar cycle and geomagnetic effects
The theory of sunlight as a risk factor for GCA has long 
been promulgated. In 1965, Kinmont and McCallum 
described 14 patients with GCA who suffered serious 
vascular complications after 'excessive' or 'merely unusual' 
sun exposure.19 They noticed that incidence was greatest 
in summer months and postulated that light sensitisation 
of the ageing skin to sunlight may provoke the acute phase 
of GCA.19 In 1978, O'Brien published evidence showing 
that long-term sun damage is common in the temporal 
arteries. He proposed that solar radiation destroys the 
essential supportive elastic tissue framework of arteries. 
As the temporal arteries run along the forehead they 
were vulnerable.24 25 In a recent US study, the impact of 
geomagnetic effects and solar cycle on the incidence of 
GCA in Olmsted County in Minnesota was investigated.26 
They found that higher geomagnetic activity was asso-
ciated with higher rate of GCA incidence. GCA rates 
peaked 0–1 year after strong magnetic activity, possibly 
suggesting that the effect is cumulative or that latency 
between environmental exposure and disease manifesta-
tion could be due to a complex autoimmune process.26 
However, in this same study, the correlation between 
solar extreme ultraviolet radiation and GCA incidence 
was also investigated, and found that the correlation was 
not as significant as geomagnetic impact.26
Socioeconomic status
In a national Swedish study, educational level, family 
income, marital status and occupation seemed to have 
only a weak relationship with GCA.22 Interestingly though, 
in this study, certain comorbidities, such as hypertension 
and type 2 diabetes, placed people at higher risk of devel-
oping GCA.22 Other case–control studies have reported 
an increased risk of GCA in heavy smokers and in patients 
with previous atherosclerotic disease,27 28 but this was not 
replicated in the Swedish cohort.22 A British study found 
that area-level socioeconomic deprivation was associated 
with ischaemic manifestations resulting from GCA. This 
is most likely because individuals living in more deprived 
areas do not seek medical attention as early and hence 
are delayed at getting treatment.29
Urban versus rural living
Some studies have found a trend, although non-sig-
nificant, that urban lifestyle may possibly predispose 
individuals at developing GCA.22 In a German study, 
in both Northern and Southern Germany, GCA has 
been significantly more prevalent in urban populations 
compared with rural populations.30 It remains unclear 















Seasonal variation in GCA (Southern hemisphere)
J F M A M J J A S O N D
Figure 1 Cosinor test for Southern Hemisphere data 
(adjusted for age and sex). GCA, giant cell arteritis.
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in the rural regions associated with differences in health-
care systems in cities versus rural areas.
dIsCussIOn
To our knowledge, our GCA data set is one of the largest 
GCA data sets worldwide. Unlike most large epidemi-
ological data sets available on GCA, our data were not 
obtained through retrospective search of primary care 
registers or other national available public health system 
databases.4 31 32 Instead, we analysed data gathered from 
the time of patients’ biopsies.
Our patient demographic is similar to previous 
studies. The female-to-male ratio was similar in both our 
Southern and Northern Hemisphere data sets (2.23 and 
2.38 respectively). This is comparable to findings from 
a ‘meta-analysis’ comprising British, North American 
and Swedish populations stating that 70.2% of patients 
with GCA in the combined studies were female (ratio 
2.39).4 In most studies, the female-to-male ratio has been 
reported at around 2.5. However, interestingly female 
predominance is less pronounced in Israel, Turkey and 
Mediterranean countries.9 33–36 The mean age of diag-
nosis in our study was 76.44 years. This is representative 
of data from other studies, indeed making it one of the 
latest onset systemic autoimmune diseases.4
Over the years, there have been numerous hypotheses 
regarding putative environmental risk factors for GCA, yet 
none have been robustly confirmed. Our study supports 
the view that there is no obvious seasonal trend of GCA 
in Australia and New Zealand. This is different from a 
recent study in South Australia which showed statistically 
significant higher rates of GCA observed in the Southern 
Hemisphere summer months, December to January,37 
and a study in New Zealand which showed a trend for 
increased incidence in spring although not statistically 
significant.8 The theory on latitude also remains conten-
tious. Latitude does not explain why Scotland has a lower 
GCA incidence rate than the rest of the UK,38 and why the 
incidence rates in Lugo (Spain) and Havsa (Turkey) are 
very different yet both locations are of very similar north-
erly latitude (43.0097°N and 41.5550°N respectively). As 
highlighted by the numerous studies in our systematic 
review (table 3), there seems to be no consensus on envi-
ronmental risk factors and their impact on the incidence 
rate of this disease.
Our study has some limitations. Our cohort of GCA 
cases comprised TAB-positive cases only. As such, our 
data set does not include TAB-negative or clinically diag-
nosed GCA cases. In addition, we were dependent on 
the ability of pathology centres to easily access archived 
TABs as we required biological sampling for a concom-
itant genetics study. As such, those FFPE blocks stored 
offsite may have been unavailable or difficult to recruit 
and hence not collected. This may have led to a non-con-
secutive recruited data set. Although we are unable 
to comment on annual fluctuations and/or epidemic 
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seasons is very evenly spread with the TAB-positive cases 
only, the exclusion of the occasional clinically diagnosed 
GCA case and/or the exclusion of the irretrievable FFPE 
block would unlikely have altered our findings.
The season in which a patient was diagnosed was esti-
mated based on the DOT. However, depending on how 
long a patient waits before seeking medical advice and/
or is being referred for appropriate investigation, clinical 
diagnosis (onset of symptoms) may precede histological 
diagnosis by weeks, even months. As such, an important 
caveat of our work is that DOT may not represent the 
actual onset of disease in each case. However, presuming 
that the length of time between onset of symptoms and 
ischaemic manifestations from GCA is relatively uniform, 
as well as the fact that the number of cases across all 
seasons was evenly spread, it is unlikely that using DOT 
as a tool to categorise patients to seasons would have 
dramatically influenced our results.
Our data set was derived from the active participation 
of a selective group of hospitals and pathology centres 
rather than through a population-based study approach 
with access to a national database. Case recruitment was 
not necessarily representative of disease activity across 
Australia and New Zealand. Certain regions may have 
been over or under-represented. We lack samples and 
data predominantly from the tropical regions due to 
lack of expressed interest from potential collaborators 
in these areas. Of the 79 FFPE samples recruited from a 
pathology centre in Queensland, 69 were recruited from 
the Brisbane area in subtropical South East Queensland 
and only 10 from tropical North Queensland.
Because of this selection bias of participating pathology 
centres, we were unable to extrapolate the incidence 
rates of GCA from certain hospitals and/or pathology 
sites to accurately represent entire regions or states. As 
such, we were unable to comment on the intra or inter-
state variation in incidence rate of GCA; we were unable 
to analyse incidence based on latitude, nor compare inci-
dence between wet and dry seasons in the more tropical 
areas.
It is also important to note that we only have data avail-
able on seasonal influence from two countries in Northern 
Europe. We incorporated their data and compared the 
influence of seasons on GCA onset between Austral-
asia and Northern Europe. Although we accounted for 
seasons in the Northern Hemisphere being the reverse of 
those in the Southern Hemisphere, the climate of each 
season in the Northern Europe is likely different from 
that of its corresponding season in Australia and New 
Zealand.
Most of our demographic data were retrieved directly 
from pathology databases. Detailed clinical information 
from medical records, including details such as smoking 
status, ethnic background and address, was not retrieved. 
Some patients would have travelled from rural areas to 
have their TAB performed in tertiary referral centres. 
However, this information was not available and so we 
cannot determine whether our recruited population has 
an urban versus rural predisposition, and whether there 
is SES association.
Irrespective of some of the limitations we faced in the 
recruitment of our demographic data, studying the role 
of environmental risk factors in disease aetiology always 
proves challenging in view of numerous confounding 
factors, which are difficult to eliminate entirely. It is diffi-
cult to draw evidence on the true effect of latitude on the 
incidence of GCA as other factors come into play and are 
hard to dissociate.39 Even when comparing two popula-
tions of similar ethnic background living at two different 
latitudes within the same country, for example, Cairns 
and Hobart in Australia (16.9186°S and 41.4545°S respec-
tively), factors such as timing of migration to Australia 
(ie, number of Generations Australian), mobility within 
Australia, lifestyle in these areas (eg, outdoor vs indoor 
activity), sun exposure, agricultural versus industrial 
workplace, fauna and flora may all influence risk.
In summary, this demographic GCA data set is one of 
the largest worldwide and certainly the largest in Austral-
asia. Our results demonstrate equal distribution of the 
incidence rate across all four seasons and hence do not 
support a seasonal component contributing to the onset 
of disease. Alongside our geoepidemiological study, our 
systematic literature review highlights that there is no 
convincing and certainly no consistent evidence for role 
of direct environmental factors on the risk of developing 
GCA.
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